Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. (Record no. 24648992)

MARC details
000 -LEADER
fixed length control field 01637 a2200517 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517020240.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201602s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-8301
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2217/fon.15.34
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mustacchi, G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160203
245 00 - TITLE STATEMENT
Title Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Future oncology (London, England)
Date of publication, distribution, etc. 2015
300 ## - PHYSICAL DESCRIPTION
Extent 1493-500 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemotherapy, Adjuvant
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Italy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trastuzumab
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Puglisi, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Molino, A M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Crivellari, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ghiotto, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ferro, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brunello, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saracchini, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Turazza, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cretella, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Iop, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Malagoli, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stefani, M
773 0# - HOST ITEM ENTRY
Title Future oncology (London, England)
Related parts vol. 11
-- no. 10
-- p. 1493-500
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2217/fon.15.34">https://doi.org/10.2217/fon.15.34</a>
Public note Available from publisher's website

No items available.